Literature DB >> 24821969

Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies.

Franziska Zabel1, Deepa Mohanan2, Juliana Bessa3, Alexander Link3, Antonia Fettelschoss2, Philippe Saudan3, Thomas M Kündig2, Martin F Bachmann4.   

Abstract

Extensive studies have been undertaken to describe naive B cells differentiating into memory B cells at a cellular and molecular level. However, relatively little is known about the fate of memory B cells upon Ag re-encounter. We have previously established a system based on virus-like particles (VLPs), which allows tracking of VLP-specific B cells by flow cytometry as well as histology. Using allotype markers, it is possible to adoptively transfer memory B cells into a naive mouse and track responses of naive and memory B cells in the same mouse under physiological conditions. We have observed that VLP-specific memory B cells quickly differentiated into plasma cells that drove the early onset of a strong humoral IgG response. However, neither IgM(+) nor IgG(+) memory B cells proliferated extensively or entered germinal centers. Remarkably, plasma cells derived from memory B cells preferentially homed to the bone marrow earlier and secreted increased levels of Abs when compared with primary plasma cells derived from naive B cells. Hence, memory B cells have the unique phenotype to differentiate into highly effective secondary plasma cells.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821969     DOI: 10.4049/jimmunol.1400065

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Meeting report VLPNPV: Sessions 1 and 2: Plenary.

Authors:  Frank Sainsbury
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Do Memory B Cells Form Secondary Germinal Centers? It Depends.

Authors:  Kathryn A Pape; Marc K Jenkins
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

3.  Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiation.

Authors:  Franziska Zabel; Antonia Fettelschoss; Monique Vogel; Pål Johansen; Thomas M Kündig; Martin F Bachmann
Journal:  Immunology       Date:  2017-01-05       Impact factor: 7.397

Review 4.  Deconstructing the germinal center, one cell at a time.

Authors:  Chad R Dufaud; Louise J McHeyzer-Williams; Michael G McHeyzer-Williams
Journal:  Curr Opin Immunol       Date:  2017-03-17       Impact factor: 7.486

Review 5.  Biologics to treat substance use disorders: Current status and new directions.

Authors:  Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2016-07-21       Impact factor: 3.452

Review 6.  Metabolic Links between Plasma Cell Survival, Secretion, and Stress.

Authors:  Wing Y Lam; Deepta Bhattacharya
Journal:  Trends Immunol       Date:  2017-09-11       Impact factor: 16.687

7.  Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response.

Authors:  Kyung Soo Park; Ian Bayles; Alec Szlachta-McGinn; Joshua Paul; Julie Boiko; Patricia Santos; June Liu; Zhou Wang; Lisa Borghesi; Christine Milcarek
Journal:  J Immunol       Date:  2014-09-19       Impact factor: 5.422

Review 8.  Adjuvant formulations for virus-like particle (VLP) based vaccines.

Authors:  Velasco Cimica; Jose M Galarza
Journal:  Clin Immunol       Date:  2017-08-03       Impact factor: 3.969

9.  Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Authors:  Peter Pushko; Lindsey M Pujanauski; Xiangjie Sun; Melissa Pearce; Rachmat Hidajat; Thomas Kort; Louis M Schwartzman; Irina Tretyakova; Liu Chunqing; Jeffery K Taubenberger; Terrence M Tumpey
Journal:  Vaccine       Date:  2015-07-21       Impact factor: 3.641

10.  Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.

Authors:  Xiaohui Li; Peter Pushko; Irina Tretyakova
Journal:  J Vaccines Vaccin       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.